![Meilin Yi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meilin Yi
No más puestos en curso
Perfil
Meilin Yi worked as a Director at Welichem Biotech, Inc..
Mr. Yi attended the University of International Business & Economics for an undergraduate degree.
Antiguos cargos conocidos de Meilin Yi.
Empresas | Cargo | Fin |
---|---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Director/Miembro de la Junta | - |
Formación de Meilin Yi.
University of International Business & Economics | Undergraduate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Meilin Yi